-Three-years working experience at leading law firms focusing on capital markets of China, Hong Kong and the U.S.-Participated in various international IPOs, Post-listing legal compliance and M&A projects.Representative Matters:o Represented Citi, ABCI and EIS, overall coordinators of Fangzhou Inc. (6086.HK), the largest online chronic disease management platform in China, in its HK IPO in July 2024;o Represented Citi, sole sponsor of Jiangxi Rimag Group Co., Ltd. (2522.HK), a leading medical group specialized in medical imaging in China, in its HK IPO in June 2024;o Represented J.P.M. and CICC, joint sponsors of Lianlian DigiTech Co., Ltd. (2598.HK), a leading digital payment company, in its HK IPO in March 2024;o Represented Gigabyte Technology Co., Ltd. (2376.TW), a leading computer manufacturer in Taiwan, in its ECB issuance on the Singapore Exchange in July 2023, and ECB and GDS issuance in July 2024;o Assisted in advising Perfect Corp. (NYSE:PERF) with respects to its respective post-listing compliance issues under the U.S. laws;o Assisted in advising Cheshi Technology Inc. (1490.HK), Kimou Environmental Holding Limited (6805.HK), China Smartpay Group Holdings Limited (8325.HK) with respect to their respective post-listing compliance issues under the Hong Kong laws.